Collagen/bone growth factor - Centerpulse

Drug Profile

Collagen/bone growth factor - Centerpulse

Alternative Names: Ne-Osteo

Latest Information Update: 01 Aug 2007

Price : $50

At a glance

  • Originator Centerpulse
  • Developer Centerpulse; Centerpulse Orthopedics; Centerpulse Spine-Tech
  • Class Biopolymers
  • Mechanism of Action Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bone disorders; Periodontal disorders

Most Recent Events

  • 16 Oct 2003 Centerpulse has been acquired by Zimmer Holdings
  • 21 Oct 2002 Sulzer Spine-Tech is now called Centerpulse Spine-Tech
  • 21 Oct 2002 Sulzer Orthopedics is now called Centerpulse Orthopedics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top